Intelligence Platform
Patents
Browse 677 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7777019
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted patentUS 7776883
Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and A
granted patentUS 7771715
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted patentUS 7771729
Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm
granted patentUS 7767645
SH2 domain binding inhibitors
granted patentUS 7763451
Methods for preparing Bacillus anthracis protective antigen for use in vaccines
granted patentUS 7763719
Variants of humanized anti-carcinoma MAb CC49
granted patentUS 7763586
Melanoma antigens and their use in diagnostic and therapeutic methods
granted patentUS 7759330
21-substituted progesterone derivatives as new antiprogestational agents
granted patentUS 7758876
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligon
granted patentUS 7758855
DNA promoters and anthrax vaccines
granted patentUS 7754676
Defensin-antigen fusion proteins
granted patentUS 7754227
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
granted patentUS 7754420
Methods of using cyanovirins to inhibit viral infection
granted patentUS 7749984
Computer-based model for identification and characterization of non-competitive inhibitors
granted patentUS 7749719
Melanoma antigens and their use in diagnostic and therapeutic methods
granted patentUS 7749967
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic
granted patentUS 7745212
Melanoma antigens and their use in diagnostic and therapeutic methods
granted patentUS 7744902
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal
granted patentUS 7745144
Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins
granted patentUS 7741437
P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
granted patentUS 7731953
Methods for use of TSLP and agonists and antagonists thereof
granted patentUS 7723096
Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the
granted patentUS 7723022
Immunostimulatory nucleic acid molecules
granted